China Resources Pharmaceutical Group Limited

HKEX:3320.HK

4.96 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016201520142013
Operating Activities:
Net Income 4,258.9354,147.4123,768.8893,297.1263,286.4193,977.6033,483.0362,821.412,850.0766,922.7736,912.913
Depreciation & Amortization 3,496.6173,152.152,821.892,444.0532,364.8471,517.4031,451.7151,182.9091,267.471,352.8031,195.697
Deferred Income Tax 0-7,715.581-6,717.00900000000
Stock Based Compensation 141.89199.5521.17200000000
Change In Working Capital 1,769.566-934.798300.318-3,762.497-2,011.833-3,341.193-5,260.507-13,243.038-6,376.389-3,638.889-3,698.97
Accounts Receivables -6,998.958-8,022.74-5,197.631-5,120.696-7,586.942-3,370.677-4,514.253-8,736.521-6,218.789-7,431.674-7,851.819
Inventory -2,948.302-2,635.656-3,410.712-805.547-537.47429.484-746.254-4,506.517-157.6-3,783.534-1,095.005
Accounts Payables 12,055.7789,363.3177,536.5481,541.0266,189.599223.66106.7899,191.1614,140.637,431.6747,851.819
Other Working Capital -338.953360.2811,372.113622.72-77.016-223.66-106.789-9,191.161-4,140.637,576.3195,247.854
Other Non Cash Items 10,367.28812,133.32911,044.9144,298.4941,614.6246,093.1525,183.29413,358.3668,247.633-449.965-307.483
Operating Cash Flow 15,007.69110,898.71411,220.4366,277.1765,254.0578,246.9654,857.5384,119.6475,988.794,186.7224,102.157
Investing Activities:
Investments In Property Plant And Equipment -3,461.644-3,356.325-2,902.867-2,218.499-2,040.512-1,516.646-1,566.712-1,718.434-1,823.189-3,188.572-2,995.475
Acquisitions Net 4,964.598-572.156-1,011.08-82.9541,034.945-4,048.856-2,026.042-2,829.556-398.882-1,018.281-3,578.879
Purchases Of Investments -26,687.844-3,047.551-1,093.77-371.448-1,603.1-3,524.692-8,573.548-15,919.383-17,422.575-15,058.347-4,321.424
Sales Maturities Of Investments 25,764.62716.3340.337536.442130.22616,988.0823,256.69218,343.4415,575.73310,949.5712,925.17
Other Investing Activites 60.8573,661.312-3,825.29114.7783,520.26-17,698.89398.043170.873149.691336.5412,181.887
Investing Cash Flow 640.594-3,298.386-8,832.67-2,021.6811,041.819-9,801.002-8,511.567-1,953.06-3,919.222-7,979.088-5,788.721
Financing Activities:
Debt Repayment -219.895-5,055.61-7,655.72-207.267-19,592.1-70,284.147-52,089.461-45,207.735-44,214.421-38,252.923-27,750.11
Common Stock Issued 03,358.44-691.064-684.77800015,061.246005,282.014
Common Stock Repurchased -571.102-483.444-86.761-145.4350000000
Dividends Paid -972.36-942.377-753.902-691.076-816.986-691.297-565.6060000
Other Financing Activities -3,124.184-5,878.6114,500.539-1,872.62911,305.83275,642.88755,781.93829,521.03142,660.13841,343.23526,476.765
Financing Cash Flow -5,581.416-9,001.6015,313.092-3,601.185-9,103.2544,667.4433,126.871-625.458-1,554.2833,090.3124,008.669
Other Information:
Effect Of Forex Changes On Cash 9.664-429.257-362.689-853.807-228.074-651.803729.64-783.823-1,036.283-737.389159.657
Net Change In Cash 10,749.939-1,209.6987,604.338584.8-2,923.352,461.603202.482757.306-520.998-1,439.4432,481.762
Cash At End Of Period 34,868.00624,118.06725,327.76517,723.42717,138.62716,636.33714,174.73413,972.25213,214.94613,735.94415,175.387